Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Eilat, Shinar"'
Autor:
Nesrin Ghanem-Zoubi, Yafit Atiya-Nasagi, Evgeniy Stoyanov, Moran Szwarcwort, Basel Darawsha, Mical Paul, Eilat Shinar
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 5, Pp 941-946 (2024)
We evaluated Q fever prevalence in blood donors and assessed the epidemiologic features of the disease in Israel in 2021. We tested serum samples for Coxeilla burnetii phase I and II IgG using immunofluorescent assay, defining a result of >200 as ser
Externí odkaz:
https://doaj.org/article/519579dcac104fecaeaa97c1183bcbab
Autor:
Dani Cohen, Marina Izak, Evgeniy Stoyanov, Michal Mandelboim, Saritte Perlman, Yonatan Amir, Sophy Goren, Anya Bialik, Limor Kliker, Nofar Atari, Ruti Yshai, Yona Zaide, Hadar Marcus, Noa Madar-Balakirski, Tomer Israely, Nir Paran, Oren Zimhony, Eilat Shinar, Yasmin Maor, Khitam Muhsen
Publikováno v:
International Journal of Infectious Diseases, Vol 132, Iss , Pp 72-79 (2023)
Objectives: The predictors of SARS-CoV-2 reinfection are unclear. We examined predictors of reinfection with pre-Omicron and Omicron variants among COVID-19-recovered individuals. Methods: Randomly selected COVID-19-recovered patients (N = 1004) who
Externí odkaz:
https://doaj.org/article/5f77e8f9a681427cbd1de9b7349733b8
Autor:
Ravit Bassal, Victoria Indenbaum, Rakefet Pando, Tal Levin, Eilat Shinar, Doron Amichay, Mira Barak, Anat Ben-Dor, Adina Bar Haim, Ella Mendelson, Dani Cohen, Tamy Shohat
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1353-1357 (2021)
Measles vaccine is administered in Israel as part of the routine childhood immunization program, at ages 1 and 6 years. In this study, we assessed seropositivity of the Israeli population against measles before the onset and propagation of the 2018
Externí odkaz:
https://doaj.org/article/0d127b05ec154ab1844154d4c480e143
Autor:
Lior Hassan, Asher Moser, Efrat Rorman, Luda Groisman, Yamit Naor, Eilat Shinar, Roni Gat, Eli Jaffe, Victor Novack, Itai Kloog, Lena Novack
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The ambient exposure does not always reflect the internal levels of pollution absorbed in the body. While human biomonitoring (HBM) could provide a valid estimate of exposure extent, it is usually an expensive and a heavily manpow
Externí odkaz:
https://doaj.org/article/6b9ab503a14542329214d904054c3ad6
Autor:
Naomi Rahimi-Levene, Jonathan Shapira, Irma Tzur, Eli Shiloah, Victoria Peer, Ella Levin, Marina Izak, Eilat Shinar, Tomer Ziv-Baran, Miriam Weinberger, Oren Zimhony, Jacob Chen, Yasmin Maor
Publikováno v:
PLoS ONE, Vol 17, Iss 7 (2022)
Several options to treat hospitalized severe COVID-19 patients have been suggested. The study aimed to describe survival in patients treated with convalescent COVID plasma (CCP) and to identify in-hospital mortality predictors. This prospective cohor
Externí odkaz:
https://doaj.org/article/bead6392495c4853ba6f71113b20536d
Autor:
Ravit Bassal, Tamy Shohat, Tal Levin, Rakefet Pando, Eilat Shinar, Doron Amichay, Mira Barak, Anat Ben-Dor, Adina Bar-Haim, Ella Mendelson, Dani Cohen, Lital Keinan-Boker, Victoria Indenbaum
Publikováno v:
Vaccines, Vol 10, Iss 7, p 996 (2022)
Mumps and rubella are vaccine-preventable viral diseases through the measles-mumps-rubella-varicella (MMRV) vaccine, administered at 12 months and again at 6 years. We assessed the sero-prevalence of mumps and rubella, identified factors associated w
Externí odkaz:
https://doaj.org/article/3037e373443d4b5fba3609657df6a24d
Autor:
Yasmin Maor, Daniel Cohen, Nir Paran, Tomer Israely, Vered Ezra, Ofra Axelrod, Eilat Shinar, Marina Izak, Galia Rahav, Naomi Rahimi-Levene, Baruch M Bazofin, Ram Gelman, Dror Dicker, Tal Brosh-Nissimov, Orli Megged, David Dahan, Avi Benov, Alona Paz, Kaykov Edward, Amit Moran, Ori Rogowski, Patrick Sorkine, Ami Mayo, Oren Zimhony, Jacob Chen
Publikováno v:
EClinicalMedicine, Vol 26, Iss , Pp 100525- (2020)
Background: We assessed outcome of patients with moderate and severe COVID-19 following treatment with convalescent plasma (CP) and the association with IgG levels in transfused CP. Methods: A prospective cohort study. Primary outcome was improvement
Externí odkaz:
https://doaj.org/article/eecd60517c3c4a7d9b10d6da187b73e7
Autor:
Yfat Yahalom-Ronen, Noam Erez, Morly Fisher, Hadas Tamir, Boaz Politi, Hagit Achdout, Sharon Melamed, Itai Glinert, Shay Weiss, Inbar Cohen-Gihon, Ofir Israeli, Marina Izak, Michal Mandelboim, Yoseph Caraco, Noa Madar-Balakirski, Adva Mechaly, Eilat Shinar, Ran Zichel, Daniel Cohen, Adi Beth-Din, Anat Zvi, Hadar Marcus, Tomer Israely, Nir Paran
Publikováno v:
Vaccines, Vol 10, Iss 2, p 291 (2022)
The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations of specifi
Externí odkaz:
https://doaj.org/article/79c4459068c048c982dd0dd04b24ee33
Autor:
Yasmin Maor, Eilat Shinar, Marina Izak, Galia Rahav, Tal Brosh-Nissimov, Asa Kessler, Naomi Rahimi-Levene, Odeda Benin-Goren, Dani Cohen, Iris Zohar, Noga Alagem, Sharon Castro, Oren Zimhony
Publikováno v:
Clinical Infectious Diseases.
Background It is unknown whether convalescent immunoglobulins (cIgG) are better than convalescent plasma (CP) for COVID-19 patients. Methods In this randomized trial we assigned high risk COVID-19 with ≤10 days of symptoms, to receive cIgG or CP. T
Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID ‐19 infection
Autor:
Dorit Blickstein, Marina Izak, Talia Filipovich‐Rimon, Osnat Garach‐Jehoshua, Naomi Rahimi‐Levene, Eilat Shinar, Ramzia Abu Hamad, Adina Bar‐Chaim, Maya Koren‐Michowitz
Publikováno v:
Vox Sanguinis.